| 
  • If you are citizen of an European Union member nation, you may not use this service unless you are at least 16 years old.

  • You already know Dokkio is an AI-powered assistant to organize & manage your digital files & messages. Very soon, Dokkio will support Outlook as well as One Drive. Check it out today!

View
 

life sciences

Page history last edited by PBworks 15 years, 9 months ago

page director:  we are recruiting for this position.  see details here...

 


 

 

 

KookyPlan Links:

 

see our page on

 

 

 

 

Stories from the net (external Links)

 

go here for a complete list, up to date... http://www.venturebeat.com/category/lifesciences

 

 

lead-tx-logo.jpgLead Therapeutics raises $17M for China-based work in cancer and immunology — San Bruno, Calif.-based Lead Therapeutics, a drug-development startup that plans to do most of its research and development in China, raised $17 million in a first funding round. Investors included Pappas Ventures, ProQuest Investments and Mustang Ventures.

We’ve previously noted a few biotech startups with strong connections to China, although for the most part these have tended to be companies founded by Chinese expatriates who raise much of their funding from Asian sources. (See, for instance, our coverage of AutekBio here and of MicuRx here.) Lead Therapeutics, by contrast, raised much of its money from traditional U.S. venture firms and will be run by a GlaxoSmithKline veteran, Peter Myers, although unsurprisingly enough, several of the company’s other executives appear to have ties to Asia. (See a list here.)

Lead Therapeutics says it has “several” drug-discovery programs going in infectious disease and cancer, but hasn’t disclosed any details to the best of my knowledge.

 

 

OTHER HEADLINES OF NOTE:

 

 

more:

 

 

 

 

 

Andy Grove: Wrong again (and again) about drug discovery

andy_grove.jpgFormer Intel chairman Andrew Grove is assailing the U.S. medical establishment again, this time with a jeremiad in which he blames the drug industry for not moving at the speed of Moore’s law. Of course, there’s plenty in the drug industry to criticize, but over at VentureBeat Life Sciences, we look at why Grove’s specific analysis is way off base, and how he also seems to overlook a major but little-noticed problem in the system — one that he’s in an excellent position to do something about. Check it out here.

 

 

 

 

Links in KookyPlan

 

  • Belgium ...It is now part of rapid growing research region in Flanders. Antwerp’s major tra...
  • Business Clusters ...The New Jersey Life Sciences Cluster ...
  • Czech Republic ...Prague is the capital of the Czech Republic and its largest city. Its main secto...
  • Denmark ...North Denmark is particularly strong in the telecommunications, IT & software, P...
  • Estonia ...Estonia boasts one of Europe's most modern telecommunications networks and a hi...
  • Fast cities ...Welcome to "Optics Valley," home to 160 mostly small outfits, such as All Optr...
  • France ...Among its other areas of expertise, the Côte d’Azur has won an international rep...
  • Germany ...Over 5,000 people are employed in Munich’s life sciences sector populated by com...
  • Ireland ...The major sectors of activity in Ireland are electronics & engineering, pharmace...
  • Israel ...Having staked his claim to fame with a number of successful investments that won...
  • LOCA ...The New Jersey Life Sciences Cluster ...
  • UK ...The city of Norwich is located in the Eastern region of the UK and has a popu...
  • USA ...Welcome to "Optics Valley," home to 160 mostly small outfits, such as All Opt...
  • Useful Resources ...life sciences companies. Members benefit from networking opportunities ...
  • innovation clusters ...The New Jersey Life Sciences Cluster ...

 

Comments (0)

You don't have permission to comment on this page.